blank
blank
National Mirror Groups bring national needs and examples of good practice into ERDERA’s annual work plans, share ERDERA outputs with organisations and communities at country level, and enable direct peer-to-peer learning between countries.​

National Mirror Groups (NMGs)

What are NMGs?

National Mirror Groups (NMGs)are national networks bringing together key peopleand organisations involved in rare diseases — including patients and patientorganisations, clinicians, researchers, funders, and national authorities.​
​
They are central to ERDERA’s national-international alignment work, helping toconnect national activity with research and knowledge at European and global levels.

blank

NMGs play a two-fold role:

  • Strengthen and coordinate the national rare disease community, building onexisting structures where these exist or creating new ones where needed.
  • Driving two-way engagementbetween national communities and largeinternational initiatives — most notably ERDERA — and with wider cross‑disease orpan‑European collaborations.

Objectives of the NMGs​

Build and/or sustain a cohesive rare disease community at national level​
Support the development and implementation of a national plan or strategy for rare disease ​
Channel national needs and good practices into ERDERA​
Disseminate and help implement ERDERA outputs at home​
Foster peer-to-peer exchange between countries ​
blank

Why does having a NMG matter?​

National Mirror Groups (NMGs)facilitate the integration of national prioritiesand best practices into ERDERA’s annual work plans.They disseminate ERDERA’s findings, tools, and opportunities within their respective countries, while fostering peer-to-peercollaboration and practical knowledge exchange across countries. NMGs can foster stronger collaborations betweenparticularcountries or groups of countries, depending on size, geography, or other commonalities.

For people living with rare diseases, this alignment is highly beneficial: itminimises redundancy, streamlines participation ininternational studies and clinical trials, and enables research outcomes, tools, and funding to reach a broader range of countries,including those with emerging research and policy frameworks for rare diseases.

We aimto set upa National Mirror Group ineverycountry involved in ERDERA. Check if yourcountry has one already.​

Want to learn more?

Visit ourdedicated pageabout National Mirror Groups, where you will find updates, essential details, contactinformation, and much more!​
​
Other relevant resources:

You might also be interested in

ERDERA workshop (3)

Webinar: The ERDERA Diagnostic Research Workstream – An overview

The session will introduce the workstream’s activities in data sharing, systematic diagnostic reanalysis, advanced diagnostic pipelines, and genomic and multi-omics innovation.
ERDERA First Policy Think Tank meeting

ERDERA Policy Think Tank meets in Paris to advance data and registry policy for rare diseases

Bringing together policy makers, researchers and data experts to align on how registry data can better support rare disease research and evidence‑based policy across Europe.
P.Sudara - Undiagnosed Day 2026

In Gdańsk, Undiagnosed Day showed why diagnosis is both a scientific and a human challenge

Bringing clinicians, researchers, patient representatives and families together, the event examined how shorter diagnostic pathways depend not only on better tests, but on shared expertise, structured phenotyping and patient-centred support.
ERDERA and european genomic data infrastructure

Strategic collaboration between GDI and ERDERA

ERDERA and the European Genomic Data Infrastructure have signed a Memorandum of Understanding to strengthen collaboration on secure cross-border access to genomic, clinical and other health-related data, supporting rare disease research and the development of personalised medicine in Europe.

ERDERA's

search form